Pain and depression in myelin oligodendrocyte glycoprotein-antibody-related disease

Takeaway

  • Chronic pain and depression are common in myelin oligodendrocyte glycoprotein-antibody-associated disease and have a huge negative impact on quality of life and daily living.

Why this matters

    Little is known about the prevalence or impact of pain and depression in myelin oligodendrocyte glycoprotein-antibody-associated disease. These important findings reveal the high prevalence of both co-morbidities and their severe impact on quality of life and highlight the need for systematic pain assessment in this disease. In addition, pain was found to be undertreated, suggesting that targeted pain treatment strategies are urgently needed.